Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1

Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1

US Patent 7309692 · Granted Dec 18, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DNA aptamers and use thereof for the treatment of cancer2024
Dual assembly nanoparticles2020
Compositions and methods for treating cancer2015
Delivery of siRNA by neutral lipid compositions2014
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes2014
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes2014
HDL particles for delivery of nucleic acids2014
Methods and compositions related to wrapping of dehydrons2013
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes2012
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes2012
Methods for treating cancer targeting transglutaminase2012
Therapeutic targeting of interleukins using siRNA in neutral liposomes2011